04:55 PM EDT, 06/05/2025 (MT Newswires) -- Ross Moat, Chief Commercial Officer, on June 03, 2025, sold 27,594 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $800,778. Following the Form 4 filing with the SEC, Moat has control over a total of 9,415 Class A common shares of the company, with 9,415 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000141588925015780/xslF345X05/form4-06052025_080613.xml